Paul Hastings Wins Five LMG Life Sciences Americas Awards
September 16, 2026
Paul Hastings received five honors at the LMG Life Sciences Americas Awards 2026, recognizing the firm’s achievements across life sciences IP litigation and transactional work.
The firm was named General Patent Litigation Firm of the Year, and Intellectual Property practice co-chair Eric W. Dittmann was named General Patent Litigator of the Year – New York. Paul Hastings also received Impact Deal of the Year – United States for Aktis Oncology’s $365 million IPO, Impact Deal of the Year – United States for Kailera Therapeutics’ $625 Million IPO and Impact Case of the Year for Allergan v. Revance Therapeutics.
These awards recognize the “most distinguished practitioners and their firms for their exemplary work in the Life Sciences legal practice” across the U.S., Canada and Brazil.
View the winners here.
About Paul Hastings
With widely recognized elite teams across 17 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers and corporations.